Phoenix Wealth Advisors Arcturus Therapeutics Holdings Inc. Transaction History

Phoenix Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$34.2 - $47.56 $6,840 - $9,512	-200 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$25.79 - $42.11 $7,737 - $12,633	-300 Reduced 60.0%	200 $7,000
Q1 2021 Apr 12, 2021	SELL	$38.75 - $86.92 $13,368 - $29,987	-345 Reduced 40.83%	500 $20,000
Q4 2020 Feb 05, 2021	BUY	$34.61 - $123.66 $29,245 - $104,492	845 New	845 $37,000

196

26.7M

294K

318K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $578M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Phoenix Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Phoenix Wealth Advisors with notifications on news.